The Shareholders Foundation announced that a deadline is coming up on January 9, 2016 in the lawsuit filed for investors of Diplomat Pharmacy Inc (NYSE:DPLO over alleged securities laws violations by Diplomat Pharmacy.
Investors who purchased shares of Diplomat Pharmacy Inc (NYSE:DPLO) have certain options and there are strict and short deadlines running. Deadline: January 9, 2016. NYSE:DPLO stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Diplomat Pharmacy Inc lacked adequate internal controls over its financial reporting, that as a result Diplomat Pharmacy Inc could not adequately calculate DIR fees, that the Company’s hepatitis C segment was not performing as previously disclosed to investors, that and therefore, Diplomat Pharmacy Inc had overstated its full-year 2016 guidance, and that that, as a result of the foregoing, Defendants’ statements about Diplomat Pharmacy Inc’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On November 2, 2016, Diplomat Pharmacy Inc reported third quarter 2016 results. Diplomat Pharmacy Inc also lowered full year 2016 guidance, with the CEO and Chairman commenting, “We are disappointed with our third quarter results, which were significantly impacted by the softness in the hepatitis C business nationwide, as well as by DIR fees. The methodology and transparency around how PBMs are applying these DIR fees changed materially in 2016, and while we cannot reverse the impact they had on this quarter, we are working with our partners in the specialty pharmacy industry and with legislators to achieve an amicable solution to this problem.” Shares of Diplomat Pharmacy Inc (NYSE:DPLO) declined to as low as $12.47 per share on November 4, 2016.
On January 6, 2017, NYSE:DPLO shares closed at $13.23 per share.
Those who purchased NYSE:DPLO shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego